Introduction
============

Lactate is an end-product of glycolysis. Under normal physiological conditions it is produced only in low concentrations, but production is increased in certain pathological states, including cerebral ischemia ([@b1]), mitochondrial disease ([@b2],[@b3]) and cancer ([@b4]--[@b6]), making it a potential biomarker in these conditions ([@b6]).

Lactate has been shown to be elevated in rodent glioma models ([@b7]). It is well known that neoplastic cells have an increased capacity for glycolytic metabolism ([@b7]) under both aerobic or anaerobic conditions as part of the malignant phenotype, thus the lactate signal would be expected to be elevated ([@b8]). Additionally, measuring the concentration of lactate in animal models has been used to monitor response to both chemotherapy and radiotherapy ([@b9]).

In the clinic, ^18^ F-fluorodeoxyglucose (^18^FDG) positron emission tomography is used to detect tumours and monitor their response to treatment by imaging their increased glucose uptake compared with normal tissue. In this situation, quantifying lactate potentially offers complementary information on (steady-state) lactate concentrations, particularly in organs such as the brain where the high glucose consumption and hence ^18^FDG uptake of normal tissue obscures their differentiation.

Measuring lactate concentration *in vivo* using ^1^H NMR is not straightforward. Lactate is an AX~3~ spin system characterized by a --CH~3~ doublet peak at 1.3 ppm, a --CH quartet at 4.1 ppm, and a *J*-coupling constant of 6.9 Hz. The quartet at 4.1 ppm is small and often affected by water suppression. Additionally, there is a large overlap between the larger signal for the lactate --CH~3~ resonance at 1.3 ppm and the --CH~2~-- resonances of lipids. This frequently leads to the lactate resonance being largely obscured by lipid signals either from surrounding tissue or in some cases from within the tumour itself ([@b10]).

Several methods have been proposed to optimize lactate signal detection in the presence of lipids, mostly by exploiting the *J*-coupling of lactate. The simplest of these is to use long echo times, which will favour lactate detection over lipid ([@b11]). This method is sufficient in tissues where lipid is lower; however, it fails to eliminate strong lipid signals, such as those often found in tumours. An alternative method is to use spin-echo difference editing. This is achieved by subtracting signal from a measurement using a non-selective refocusing pulse from one with a selective refocusing pulse. The lactate signals, therefore, add while any singlets are cancelled, including signal from lipids ([@b12],[@b13]). A significant problem with this method is that even small tissue motion leads to incomplete subtraction of the large lipid signals. There are 2D methods for lactate detection, such as *J*-resolved spectroscopy ([@b14]). These have been shown to offer good discrimination between lactate and lipid in human brain tumours ([@b15]); however, the acquisition time is long and the method suffers from motion artifacts. Another technique suggested is the use of multiple quantum filtering, which offers a compromise between detection of the lactate signal and suppression of that from lipid ([@b16],[@b17]). This method uses a series of RF pulses and magnetic gradients to select for specific quantum coherence pathways for the lactate signal. This technique has proved to be able to detect low level lactate signals *in vivo* ([@b18],[@b19]).

The purpose of this study was to evaluate a 2D chemical shift imaging (2D-CSI) version of this multiple quantum filtering technique (outlined by Mellon *et al*. ([@b20])) at 1.5 T. The technique was initially tested on phantoms to determine the lactate detection and lipid suppression efficiencies of the sequence and then trialled on a group of brain tumour patients in order to determine its effectiveness in detecting lactate in this cohort.

Experimental methods
====================

All studies were performed using a 1.5 T Siemens Avanto (Siemens Medical Systems, Erlangen, Germany). Phantom studies were performed using the standard body and phased array receiver coils, due to the large size of the phantoms. Patient studies were performed using the standard (receive only) head coil (12 elements, automatically combined by scanner software). The selective multiple quantum coherence (SelMQC)-CSI sequence ([@b20]) (Fig.[1](#fig01){ref-type="fig"}) was made available to us by Professor Jerry Glickson\'s group at the University of Pennsylvania ([@b20]). The main difference from the previously published sequence is the removal of the Hadamard encoding segment, so that the sequence becomes a single slice with a shorter minimum scan time. It was performed with *T*~R~ = 1500 ms, *T*~E~ = 144 ms, a 16 × 16 grid of cubic voxels (20 mm side), 20 mm slice thickness, 2 kHz bandwidth, dwell time = 0.5 ms, 1024 complex spectral points, one average, *Q*~sel~ gradient strength 26 mT/m, and acquisition time 6 m 24 s. The durations of the excitation pulse, the selective double quantum creation and detection pulses, and the refocusing pulse were 3 ms, 7 ms, and 7.6 ms respectively. The duration of the multiple quantum (MQ) mixing period was 17.5 ms. Point-resolved spectroscopy (PRESS)-localized single voxel spectroscopy (SVS) was used to collect data quickly to provide a water concentration reference (*T*~E~ = 135 ms, (20 mm)^3^ cubic voxel, *T*~R~ = 1500 ms, four averages). Institutional review board approval was granted for these additional sequence acquisitions.

![SelMQC-CSI sequence, courtesy of the group of Professor Jerry Glickson, with modifications by Dr Seung-Cheol ([@b20]). An initial slice-selective pulse is followed by a 72 ms evolution period. Following this is the multiple quantum coherence module, starting with the antiphase magnetization being split into double quantum and zero quantum coherences by a 90° frequency selective Gaussian at 4.1 ppm (CH). Coherence selection gradients are in a 1:2 ratio, followed by phase encoding in two planes for 2D-CSI measurement.](nbm0028-0338-f1){#fig01}

Water measurement
-----------------

To determine the validity of using SVS for the water reference measurements as opposed to CSI, CSI and SVS experiments were compared. 2D PRESS-CSI (*T*~E~ = 135 ms, *T*~R~ = 1500 ms, one average, 16 × 16 grid) and SVS (*T*~E~ = 135 ms, cubic voxel, *T*~R~ = 1500 ms, four averages) experiments were performed on a spherical (diameter = 150 mm) phantom containing a solution of brain metabolites (Phantom 1) (range of voxel sizes: side 10 mm; 12 mm; 14 mm; 16 mm; 18 mm). The area under each water peak was calculated using the water referencing algorithm in the Java version of the Magnetic Resonance User Interface (jMRUI) ([@b21]), and a comparison was made between CSI and SVS across voxel sizes. Data were compared using Bland--Altman analysis ([@b22]).

Phantom studies
---------------

A high quality (six averages) SelMQC-CSI spectrum from a cubic phantom (50 mm side) (Phantom2) containing a 20 mM lactate solution (16 × 16 grid of (35 mm)^3^ cubic voxels, 35 mm slice thickness) was collected for comparison with a single quantum lactate spectrum.

A SelMQC-CSI experiment with only one average was performed on a spherical phantom containing a solution of brain metabolites (Phantom 1) (12.5 mM N-acetylaspartate, 10 mM creatine, 5 mM lactate, 12.5 mM L-glutamic acid, 3 mM choline, 7.5 mM myo-inositol, and 50 mM KH~2~PO~4~). This was to assess how the fitting would perform on SelMQC-CSI spectra with lower signal to noise ratios, and in the presence of other metabolites.

Water reference data were collected by performing SVS experiments (*T*~E~ = 135 ms, (20 mm)^3^ cubic voxel, *T*~R~ = 1500 ms, four averages).

In order to correct for relaxation effects the longitudinal relaxation time constant (*T*~1~) and transverse relaxation time constant (*T*~2~) were measured for water and lactate in Phantoms 1 and 2. *T*~1~ was measured using a PRESS-localized saturation-recovery scheme, while *T*~2~ was measured using the same sequence with a range of echo times. Parameters were calculated using a non-linear least-squares fit between the data and the appropriate saturation-recovery and decaying exponential curves (MATLAB, MathWorks, Natick, MA, USA).

To evaluate the efficiency of lactate detection and lipid suppression, samples of lactate (20 mM) and 100% safflower oil (as in the paper by Mellon *et al*. ([@b20])) were prepared in 15 ml spherical perspex phantoms, which were then submerged in water one at a time (Phantom 3). The SelMQC-CSI sequence and standard single quantum PRESS-CSI were performed with the same parameters. For the PRESS-CSI, the in-plane PRESS box was set to 160 mm × 160 mm, with slice thickness of 30 mm.

Patient studies
---------------

The SelMQC-CSI sequence was performed with (20 mm)^3^ voxel size after a standard imaging investigation (including administration of contrast agent) on patients with either glioma (*N* = 20) or secondary metastases (*N* = 3) in the brain. Pathological diagnoses were glioblastoma multiforme (GBM, *n* = 14), anaplastic oligodendroglioma (*n* = 1), subependymal giant cell astrocytoma (*n* = 2), low grade glioma (LGG, *n* = 3), ungraded glioma (*n* = 1), and brain metastasis (*n* = 3). Patients had previously received either a partial resection or a total resection of the tumour. Two of the three patients with LGG had received chemotherapy. Those patients with a GBM had previously received radiotherapy with chemotherapy, but had relapsed by the time of these scans. No effect due to the presence of titanium screws was seen in any of the spectra.

Data were acquired using the standard head coil. The shim volume was placed over the tumour and shimming was performed manually. Saturation slices were placed over the scalp and ventricles. In this pilot study standard single quantum PRESS-localized single voxel spectra (*T*~E~ = 135 ms, (20 mm)^3^ cubic voxel, *T*~R~ = 1500 ms, 128 averages) were acquired to compare lactate visibility between the multiple quantum filtered and standard sequences. Single voxel data were collected rather than PRESS-localized CSI due to time constraints. Voxels were placed centrally over the tumour, avoiding resection cavities and necrosis where possible.

Water reference data were collected using an SVS experiment, as for phantom studies.

Processing
----------

All spectra were processed using the QUEST (Quantitation based on Quantum Estimation) package in jMRUI ([@b21]), fitting with a lactate doublet lineshape. Approximate concentrations were calculated, including correcting for *T*~1~ of water (approximately 1135 ms in brain ([@b23])) and lactate (approximately 1250 ms in brain ([@b24])), and for *T*~2~ of water (around 89 ms in brain ([@b23])). Corrections were not made for the *T*~2~ relaxation time of lactate, as reported values for this have a large range (280--1200 ms in glioma) ([@b23]--[@b26]). However owing to the long *T*~2~ of lactate this correction is likely to be small. The water concentration was assumed to be 55 M within phantoms and 30 M within tumours ([@b27]).

Results
=======

Phantom experiments
-------------------

### Water measurement

Standard single quantum CSI and SVS experiments performed over a range of voxel sizes (side of 10 mm, 12 mm, 14 mm, 16 mm, 18 mm) showed that the two methods offered similar values for the area under the water peak, *A* (calculated using the water referencing algorithm in jMRUI). The average value for the ratio *A*~SVS~/*A*~CSI~ was 0.93, with 95% limits of agreement of 0.91--0.96. Thus while there is a small bias (which can be included in the calculation), since SVS measurements take significantly less time, in comparison with CSI, this justified the use of SVS to measure the water reference signal in further experiments.

### Estimated concentrations

SelMQC-CSI spectra from the cubic phantom containing 20 mM lactate solution (Phantom 2) were processed using the QUEST package in jMRUI. The measured *T*~1~ values of water and lactate were 2919 ± 89 ms and 1830 ± 26 ms, with corresponding *T*~2~ values of 1915 ± 28 ms and 942 ± 25 ms respectively (mean ± standard error, estimated from the goodness of fit to the theoretical decay curves). The calculated concentration of lactate in the phantom (including the corrections for relaxation and for the difference in signals between SVS and CSI measurements of water) was 16.3 ± 0.5 mM (fractional Cramer--Rao lower bound (CRLB) = 1 × 10^−9^), assuming a water concentration of 55 M. This result is an underestimate of 19% compared with the true value of 20 mM.

A SelMQC-CSI spectrum from the brain metabolite phantom (Phantom 1) was also fitted using QUEST (Fig.[2](#fig02){ref-type="fig"}). The measured values of *T*~1~ and *T*~2~ were much shorter in this phantom, with *T*~1~ values of water and lactate being 389 ± 8 ms and 636 ± 41 ms, and corresponding *T*~2~ values being 317 ± 1 ms and 437 ± 13 ms respectively. This gave a calculated concentration of 4.47 ± 0.13 mM (fractional CRLB = 0.08). The quoted concentration of lactate in the solution was 5 mM.

![Data from Phantom 1 containing a solution of major brain metabolites (3 mM choline, 10 mM creatine, 12.5 mM glutamate, 12.5 mM NAA, 7.5 mM myo-inositol, and 5 mM lactate, plus 50 mM KH~2~PO~4~, 56 mM NaOH, 0.1% azide, and 0.1% Gd-DTPA). The phantom was 150 mm in diameter, using a 16 × 16 grid of (20 mm)^3^ voxels. All data were apodized with 1 Hz line-broadening prior to Fourier transformation and phase correction. (A) PRESS-localized single voxel spectrum (*T*~E~ = 135 ms, voxel size = (25 mm)^3^, 128 averages). (B) SelMQC-CSI spectrum fitted using jMRUI with an experimentally derived basis set. Bottom: SelMQC-CSI spectrum (red) with jMRUI model fit (blue). The peaks between 2 and 3 ppm arise from coupled spins, primarily glutamate, that are not totally eliminated by the MQ filter. Middle: estimate for the peak. Top: residual.](nbm0028-0338-f2){#fig02}

### Lactate detection and lipid suppression (Phantom 3)

Single quantum PRESS-CSI and SelMQC-CSI spectra of lactate are shown in Figure[3](#fig03){ref-type="fig"}(a), (b). There is 49% retention of the lactate doublet peak height at 1.3 ppm, with noise levels being similar between the two sequences.

![Data from 20 mM lactate solution (a), (b) and safflower oil phantoms (c), (d). (a), (c) Single quantum spectra for lactate and safflower oil respectively; (b), (d) the corresponding SelMQC-CSI spectra.](nbm0028-0338-f3){#fig03}

Single quantum PRESS-CSI and SelMQC-CSI spectra of safflower oil (Fig.[3](#fig03){ref-type="fig"}(c), (d)) indicated that the peak height for the lipid resonance at 1.3 ppm in the PRESS-CSI spectrum was approximately two orders of magnitude larger than that for the 20 mM lactate solution (Fig.[3](#fig03){ref-type="fig"}(c)). In the SelMQC-CSI spectrum (Fig.[3](#fig03){ref-type="fig"}(d)) there was approximately a 98% reduction in the lipid peak at 1.3 ppm. The lipid peak at 2 ppm is not significantly attenuated by the SelMQC sequence owing to its coupling with the vinyl peak at 5.3 ppm as previously observed ([@b20]); however, this is far enough removed from the lactate peak at 1.3 ppm for it not to interfere with quantification.

### Detection threshold (Phantom 1)

The signal-to-noise ratio (SNR, calculated as peak height divided by root mean square noise) of the SelMQC-CSI lactate peak in Phantom 1 containing 20 mM lactate solution (16 × 16 grid, voxel size = (20 mm)^3^, one average) is approximately 19. This suggests that the minimum concentration of lactate detectable *in vivo* is of the order of 1 mM (i.e. for SNR \> 1), with use of this coil, sequence, and parameters.

Patients
--------

An example of voxel placement in an LGG is shown in Figure[4](#fig04){ref-type="fig"}. In 15 patients with glioma the SelMQC-CSI spectrum of the tumours showed a distinct lactate signal at 1.3 ppm. Two examples are shown in Figure[5](#fig05){ref-type="fig"}: an LGG (Fig.[5](#fig05){ref-type="fig"}(b)) and a relapsed GBM (Fig.[5](#fig05){ref-type="fig"}(d)). In contrast, standard single quantum SVS spectra showed a combination of signals from both lactate and lipids (Fig.[5](#fig05){ref-type="fig"}(a), (c)). This overlap was more problematic in the relapsed GBM and anaplastic oligodendroglioma spectra, with some cases in which the lipid fully obscured the lactate signal, while in other cases it overlapped to the extent that lactate was not able to be reliably quantified. In the standard spectra, lactate could only be measured with confidence in two spectra from relapsed GBMs, whereas in the SelMQC-CSI lactate was clearly resolved in all relapsed GBMs. In the metastatic lesions there were no distinguishable peaks at 1.3 ppm in either the PRESS or the SelMQC-CSI spectra.

![Example placement of (a) SelMQC-CSI grid and (b) corresponding PRESS voxel on *T*~1~-weighted images of patient with glioblastoma following adminstration of contrast agent. In (a) the black-edging indicates the voxel corresponding to the tumour and the white-edged region is the shim volume. Saturation slices to suppress lipid under the scalp are shown hatched. The white cross-hairs visible indicate the location of orthogonal slices currently viewed, but have no significance here.](nbm0028-0338-f4){#fig04}

![Example SVS and SelMQC-CSI data from patients with LGG (a), (b) and glioblastoma (c), (d). (a) SVS spectra for LGG show a distinct lactate doublet at 1.3 ppm, with no visible signal for lipids. (b) SelMQC-CSI data show a distinct lactate doublet. Vertical scale as (a). (c) SVS spectra for GBM show a combination of in phase lipid signal and antiphase lactate at 1.3 ppm. (d) SelMQC-CSI spectra for this patient show only the doublet for lactate. Vertical scale as (c).](nbm0028-0338-f5){#fig05}

The SelMQC-CSI spectra were fitted in QUEST, showing significantly higher lactate in GBM (7.3 ± 1.9 mM, mean ± standard deviation) compared with LGG (1.9 ± 1.5 mM, *p* = 0.049).

Discussion
==========

This study has successfully shown that SelMQC-CSI provides better quantification of lactate in regions of elevated lipid signal. The sequence was tested for lactate detection efficiency, where 49% retention of the signal was recorded compared with the standard PRESS-CSI sequence. In principle the SelMQC sequence can only recover 50% of the lactate signal, due to the selection of a single coherence-transfer pathway ([@b28]), thus this value of 49% is very close to the theoretical maximum. When quantified in two different phantoms the SelMQC sequence yielded approximately the expected values, but underestimated lactate concentrations by approximately 19% and 11%. The cause of this loss is not totally clear, but it is likely to be a combination of losses in the sequence, probably including imperfect refocusing, which will affect both PRESS-CSI and SelMQC-CSI sequences. Measurements of lactate concentrations *in vivo* are also likely to suffer from this underestimate, as well as from greater uncertainty in the relaxation corrections, since it is not practicable to measure the relaxation times in each tumour (especially for the lactate resonance). Lactate peaks *in vivo* will often have a lower SNR than in the phantom, increasing the uncertainty in the fit, but this should be reflected in the CRLB estimate produced by the fitting package (jMRUI).

For future studies we suggest using MRSI measurements for the tissue water reference, since this will ensure greater consistency in measurement technique, and the possibility to estimate lactate concentrations in a greater range of voxels. A short *T*~E~ for this measurement would also reduce the dependence of the calculated concentrations on the *T*~2~ of water.

The SelMQC-CSI sequence suppresses signal from the 1.3 ppm lipid peak with a reduction of more than 98%. In order to avoid misidentifying residual lipid as lactate, the SNR of the SelMQC lactate peak must therefore be much larger than 2% of that of the 1.3 ppm lipid in the corresponding non-filtered spectrum. The estimated lipid suppression may be insufficient in some extracranial tissues, where lipid may be significantly higher. For some applications outside the brain, further optimization of lipid suppression would be required.

When the SelMQC-CSI sequence was applied in a group of previously treated brain tumours, it was shown to be able to detect lactate *in vivo* even in the presence of high lipid signals. A previous report stated that lactate is present in higher concentrations in newly diagnosed high grade glioma compared with low grade ([@b5]), in keeping with what we present here in a group of treated gliomas.

It may be noted that the Sel-MQC lactate yield in Figure[5](#fig05){ref-type="fig"}(b) appears to be more than 50% of the standard measurement in Figure[5](#fig05){ref-type="fig"}(a). There are two potential contributions to this effect. First, unresolved lipid signal may be present in (a) that still subtracts from apparent lactate signal (this is more obvious in (c)). Second, SVS lactate spectra suffer from partial volume subtraction effects ([@b29]). This reduces the total measured lactate signal from PRESS-localized single voxel spectra. For quantifying lactate using standard PRESS localization this effect needs to be taken into account (but it is not required for the work presented here).

Glioma xenograft studies have shown that glycolysis is more prominent in hypoxic areas than in diffuse infiltrative growth ([@b30]). Therefore, lactate measurements have great potential as a biomarker of response in therapies that induce hypoxia such as radiotherapy. Furthermore, evaluation of first line treatment with adjuvant radiotherapy and temozolomide is sometimes difficult owing to the phenomenon of pseudoprogression on contrast-enhanced MRI ([@b31]), which is difficult to differentiate from true progression and may be helped by including measurement of tissue lactate content. The problem of lipids interfering with lactate signal is probably greatest with high grade tumours, as lipids may also reflect severity of tissue damage ([@b5]).

Conclusions
===========

This study showed that the SelMQC-CSI technique offers a good means of lipid suppression while maintaining good lactate detection efficiency. Lactate was successfully measured in both phantoms and in a range of brain tumours. Prior experiments with this sequence have been performed at 3 T; this study shows that the method is also clinically useful at 1.5 T, with a minimum detection threshold of approximately 1 mM for a 6.5 min acquisition. Further study with this sequence will include expansion of the brain tumour group to study lactate in non-enhancing peritumoral regions and the evaluation of lactate in extracranial tumours.
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CRLB

:   Cramer--Rao lower bound

CSI

:   chemical shift imaging

^18^FDG

:   ^18^F-fluorodeoxyglucose

GBM

:   glioblastoma multiforme

jMRUI

:   Java version of the Magnetic Resonance User Interface

LGG

:   low grade glioma

PRESS

:   point-resolved spectroscopy

QUEST

:   Quantitation based on Quantum Estimation

SelMQC

:   selective multiple quantum coherence

SNR

:   signal-to-noise ratio

SVS

:   single voxel spectroscopy
